Stocktoria
Ultragenyx Pharmaceutical Inc. RARE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-01-31
Ultragenyx Pharmaceutical Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. | director | 2026-06-15 | Sell | 2,000 | $25.05 |
| Parschauer Karah Herdman | EVP and Chief Legal Officer | 2026-06-15 | Sell | 1,899 | $24.62 |
| Horn Howard | Chief Financial Officer | 2026-06-01 | Sell | 4,653 | $23.77 |
| SULIMAN SHEHNAAZ | director | 2026-05-18 | Sell | 5,740 | $25.12 |
| SULIMAN SHEHNAAZ | director | 2026-05-14 | Grant | 7,751 | — |
| Fust Matthew K | director | 2026-05-14 | Grant | 7,751 | — |
| Ray Amrit | director | 2026-05-14 | Grant | 7,751 | — |
| Sanders Corazon (Corsee) D. | director | 2026-05-14 | Grant | 7,751 | — |
Source: SEC EDGAR filings · CIK 0001515673 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.